Utilization of peripheral blood stem cells in autotransplantation

A. Kessinger

Research output: Contribution to journalArticle

23 Scopus citations


Autologous blood-derived hematopoietic progenitors can be used like autologous bone marrow to restore hematopoiesis following marrow ablative therapy. Peripheral stem cell transplantation (PSCT) is preferable to autologous bone marrow transplantation (ABMT) if autologous marrow is not suitable for use as a graft product. Generally, this unsuitability results from marrow hypocellularity or metastatic disease. PSCT also has an advantage over ABMT in that it often restores marrow function more rapidly.

Original languageEnglish (US)
Pages (from-to)535-545
Number of pages11
JournalHematology/Oncology Clinics of North America
Issue number3
Publication statusPublished - Jan 1 1993


ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this